In obesity-associated breast cancer, adipocytes are able to recruit macrophages by a novel signaling pathway involving IL-1β and the chemotactic factor CCL2 (also known as MCP-1) that in turn activate CXCL12 promoting angiogenesis and tumor development (170). Here, CCL2 is linked to obesity due to melanocortin 4 receptor deficiency.